EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The HFpEF-ABA score predicts adverse cardiac remodelling and incident heart failure: a UK biobank study

Qingbo Shi iD, Yang Gao, Donghui Chen, Zhuocheng Shi, Chaowei Zhang, Yushuo Gu, Boyi Shi, Cao Ma, Zhiwen Zhang, Xingwei Wang, Yunxia Wang, Quan Guo und 2 weitere

ESC Heart Failure · 04.07.2026 · 13 (4)

DOI: 10.1093/eschf/xvag171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 07.07.2026. Verfasst von Qingbo Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan 450000,…. Hauptthemen laut MEDLINE: Heart Failure, Ventricular Remodeling, Stroke Volume, Biological Specimen Banks. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Provincial Special Research Project on Traditional Chinese Medicine, Henan Cardiovascular Disease Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The HFpEF-ABA score (age, body mass index, atrial fibrillation) was originally derived to diagnose heart failure with preserved ejection fraction (HFpEF) in symptomatic patients. However, its utility as a preventive screening tool to identify preclinical risk in unselected community populations remains unvalidated. To validate the HFpEF-ABA score in a large community-based cohort free of heart failure and structural heart disease, utilizing a dual validation approach combining cardiac magnetic resonance phenotyping and long-term outcome prediction.

Methods

We analysed 416 374 UK Biobank participants without baseline heart failure. Participants were stratified by HFpEF-ABA score into low, intermediate, and high risk. We assessed biological validity in a subcohort of 65 293 participants utilizing cardiac magnetic resonance, and clinical validity via prospective adjudication of heart failure hospitalization over a median follow-up of 14.9 years.

Results

Structurally, elevated scores identified characteristic patterns of adverse cardiac remodelling in individuals at high risk for incident heart failure despite the absence of a clinical diagnosis: high-risk individuals exhibited profound left atrial dysfunction (LA ejection fraction 55.48% vs. 61.92%, P < .001) and distinct concentric ventricular remodelling compared with low-risk participants. Clinically, this structural substrate translated into a 6.4-fold excess risk of incident heart failure hospitalization (hazard ratio [HR] 6.44, 95% confidence interval [CI] 5.86–7.08, P < .001) and a 3.5-fold increased risk of the composite outcome (P < .001). The score demonstrated robust discrimination, outperforming its individual components.

Conclusion

The HFpEF-ABA score demonstrates significant prognostic value for identifying individuals at high risk for incident heart failure and is associated with adverse cardiac remodelling and subclinical cardiac changes. These findings support repositioning the score from a diagnostic aid to a population-level screening instrument, supporting earlier identification of high-risk individuals before overt clinical heart failure develops.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureVentricular RemodelingStroke VolumeBiological Specimen BanksVentricular Function, LeftHumansFemaleUnited KingdomMaleIncidencePrognosisAgedRisk AssessmentProspective StudiesMagnetic Resonance Imaging, CineMiddle AgedFollow-Up StudiesUK BiobankRisk Factors

Stichwörter der Autor:innen

Cardiac magnetic resonanceHFpEF-ABA scoreHeart failurePreventive screeningRisk stratification

Autor:innen und Institutionen

  • Department of Cardiology, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan 450000, China.
  • Department of Cardiology, Zhengzhou University People's Hospital, Zhengzhou, Henan 450000, China.
  • The First Clinical School of Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Department of Radiology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Henan Provincial Clinical Research Center for Cardiovascular Disease, Zhengzhou, Henan 450000, China.
  • Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Zhengzhou, Henan 450000, China.

ORCID-Profile: Qingbo Shi

Förderung

  • National Natural Science Foundation of China
  • Henan Provincial Special Research Project on Traditional Chinese Medicine
  • Henan Cardiovascular Disease Center

Zitieren

APA

Shi, Q., Gao, Y., Chen, D., Shi, Z., Zhang, C., Gu, Y., Shi, B., Ma, C., Zhang, Z., Wang, X., Wang, Y., Guo, Q., Geng, B., & Li, M. (2026). The HFpEF-ABA score predicts adverse cardiac remodelling and incident heart failure: a UK biobank study. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag171

Vancouver

Shi Q, Gao Y, Chen D, Shi Z, Zhang C, Gu Y, et al. The HFpEF-ABA score predicts adverse cardiac remodelling and incident heart failure: a UK biobank study. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag171

BibTeX
@article{Shi2026,
  author = {Shi, Qingbo and Gao, Yang and Chen, Donghui and Shi, Zhuocheng and Zhang, Chaowei and Gu, Yushuo and Shi, Boyi and Ma, Cao and Zhang, Zhiwen and Wang, Xingwei and Wang, Yunxia and Guo, Quan and Geng, Bingchuan and Li, Muwei},
  title = {The HFpEF-ABA score predicts adverse cardiac remodelling and incident heart failure: a UK biobank study},
  journal = {ESC Heart Failure},
  year = {2026},
  volume = {13},
  number = {4},
  doi = {10.1093/eschf/xvag171}
}
Kostenlos starten →